Activation of the Akt pathway renders tumour cells more resistant to Myc as an oncogenic driver, generating rare stem cell‐like cells that retain the original AT2 lineage, thereby overcoming the transformation bottleneck.201, 202. Here, MYC is linked to neoplasm.